PATENT CLAIM ANALYSIS

Application Number: 16264097
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["548", "469000"]

Abstract:
The present invention relates to indole compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of P2X7, and for the treatment of P2X7-related disorders.

Claim (Index 28):
A method for treating a P2X7-mediated disease or disorder, which disease or disorder is: Parkinson's disease; multiple sclerosis (MS); Alzheimer's disease; traumatic brain injury; encephalitis; depression mania; bipolar disease; anxiety; schizophrenia; an eating disorder; a sleep disorder; a cognition disorder; epilepsy; seizure disorder; urinary incontinence; urinary hesitancy; rectal hypersensitivity; fecal incontinence; benign prostatic hypertrophy; inflammatory bowel disease; allergic rhinitis; asthma; reactive airway disease; chronic obstructive pulmonary disease; rheumatoid arthritis; osteoarthritis; myocardial infarction; uveitis; atherosclerosis; or psoriasis; in a subject having the disease or disorder, comprising the step of administering to said subject a compound of  claim 19 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.16667
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15370645', '14969328', '14814659', '14730351', '15626138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7367787060827772
- 35 USC 102 Novelty (BERT): 0.5120185146846274
- Combined Prediction Score: 0.7143026869429623
- Mean Citation Score: 266.416144
- Max Citation Score: 289.2787
- Similarity Product: 193.82988974407908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test